Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
LUMN has dropped another 15% this week, reaching $4.99 on Tuesday and extending a punishing decline that has now erased 28% over the past month.
The short-covering story from the October 12 note has shifted. Short interest climbed 5% in a single session on October 13, reversing a brief retreat and pushing SI back to 6.7% of the free float. That is still below the mid-September peak of roughly 7.7%, so the broader unwinding trend remains intact, but the single-day rebuild is worth noting. The lending market offers no particular alarm. Availability remains extremely loose, with shares available to borrow running at roughly 1,662% of current short interest, well above even the 52-week low availability reading of 1,371%. Cost to borrow has actually fallen sharply, down 28% on the week to just 0.36%, the lowest reading in the 30-day history. Shorts rebuilding into a falling stock are doing so cheaply and without any friction from the lending pool. Options traders are only modestly more defensive than usual. The put/call ratio of 0.73 sits just 0.6 standard deviations above its 20-day mean of 0.71, a long way from the 52-week high of 1.01. That is not a signal of acute fear.
The Street holds a consensus rating of hold, with a mean price target of $7.49. At $4.99, that implies roughly 50% upside to the consensus, but the analyst register has seen no recent changes, and with the stock having lost half its value since June, some of those targets may not yet reflect the current trading level. The EV/EBITDA multiple has compressed to 7.0x, down about 0.12x over the past month as the share price has fallen faster than debt assumptions have been revised. The earnings-per-share surprise factor score of 85 is one of the few bright spots in the data, suggesting the company has repeatedly beaten lowered expectations. The short score has eased from 48.5 to 46.6 over the past two weeks, a mild improvement that puts it in roughly the 27th percentile for short pressure relative to peers, modest rather than extreme.
Insider activity gives a small counterpoint to the relentless price decline. CEO Kathleen Johnson made an open-market purchase of 100,000 shares at $6.13 on August 6, committing $613,000 of personal capital with no 10b5-1 plan attached. That trade was discretionary and executed at a price now 19% above the current market. The net insider position over the past 90 days is positive, with no open-market sales recorded from senior executives. BlackRock holds 13.8% of shares and added nearly 9.75 million shares in the period to September 30. FMR added 13.9 million shares in the same window. Those are the two largest accumulations in the top-15 holder list, running against the directional price move.
Wikipedia attention for Lumen is running at a z-score of 3.2 relative to its own 90-day history, a meaningful spike in retail interest likely reflecting the scale of recent price falls rather than any product catalyst. The company has no alt-data series that has been measured to lead its reported figures, so the attention spike is colour rather than signal.
The next earnings print is scheduled for November 3, 20 days away. The last two releases produced sharp one-day moves of minus 5.7% and minus 0.3% respectively, so the market's reaction to the print will be the clearest near-term test of whether the August low was a floor or a way-station.
See the live data behind this article on ORTEX.
Open LUMN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
